Search
ATAI Life Sciences NV
ATAIAdd to Watchlist
7.350USD
0.0000.00%
Market hours 09/10, 15:59（ET）
2.72BMarket Cap
LossP/E TTM
ATAI Life Sciences NV (ATAI) Stock Price Target & Forecast
Analyst Rating
Based on 15 analysts giving stock ratings to ATAI Life Sciences NV in the past month.
--
1 Strong Buy
3 Buy
11 Hold
0 Sell
0 Strong Sell
Target Price
9.000USD+22.45%
ATAI Analyst Recommendation Trends
In the current month, ATAI has received 3 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. ATAI average Analyst price target in the last month is 9.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
3
3
3
3
2
2
3
5
11
11
10
10
10
9
11
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
15
14
14
13
13
12
11
ATAI Analyst Rating for Peer Comparison
Updated: Oct 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Financial Forecasting
Based on analysts' estimates, ATAI EPS is projected to reach -0.103 in FY2026Q3, following reported EPS of -0.090 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.11
-0.10
-0.10
-0.10
-0.09
Actual
-1.73
-0.08
-0.09
--
--
Surprise
-1515.19%
+18.31%
+9.84%
--
--
FAQs
What is ATAI Life Sciences NV's expected revenue for the next quarter?
ATAI Life Sciences NV's expected revenue is 750.00K.
What is ATAI Life Sciences NV's price target?
Analysts forecast that ATAI Life Sciences NV's price target is USD 9.22, with the highest forecast at USD 16.00 and the lowest forecast at USD 6.75.
How have ATAI Life Sciences NVATAI's recent earnings per share performed?
The market expectation was USD -0.09, while ATAI Life Sciences NVATAI's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.10.